BeiGene, Ltd. (6160.HK)

HKD 105.9

(-1.4%)

Net Debt Summary of BeiGene, Ltd.

  • BeiGene, Ltd.'s latest annual net debt in 2023 was -2.24 Billion USD , up 24.74% from previous year.
  • BeiGene, Ltd.'s latest quarterly net debt in 2024 Q2 was -1.5 Billion USD , up 13.15% from previous quarter.
  • BeiGene, Ltd. reported annual net debt of -2.97 Billion USD in 2022, up 19.09% from previous year.
  • BeiGene, Ltd. reported annual net debt of -3.68 Billion USD in 2021, down -348.91% from previous year.
  • BeiGene, Ltd. reported quarterly net debt of -1.73 Billion USD for 2024 Q1, up 22.81% from previous quarter.
  • BeiGene, Ltd. reported quarterly net debt of -2.24 Billion USD for 2023 Q4, up 9.89% from previous quarter.

Annual Net Debt Chart of BeiGene, Ltd. (2023 - 2013)

Historical Annual Net Debt of BeiGene, Ltd. (2023 - 2013)

Year Net Debt Net Debt Growth
2023 -2.24 Billion USD 24.74%
2022 -2.97 Billion USD 19.09%
2021 -3.68 Billion USD -348.91%
2020 -819.98 Million USD -140.7%
2019 -340.66 Million USD 33.79%
2018 -514.53 Million USD -587.08%
2017 -74.88 Million USD -6.63%
2016 -70.23 Million USD -2507.61%
2015 2.91 Million USD 4961.67%
2014 -60 Thousand USD -100.26%
2013 23.43 Million USD 0.0%

Peer Net Debt Comparison of BeiGene, Ltd.

Name Net Debt Net Debt Difference
Uni-Bio Science Group Limited -76.36 Million HKD -2835.242%
CK Life Sciences Int'l., (Holdings) Inc. 5.26 Billion HKD 142.561%